Paul Ehrlich and Ludwig Darmstaedter Prize

The Paul Ehrlich and Ludwig Darmstaedter Prize is given every year since 1952 for investigations in medicine. The prize carries a prize money of 100.000 Euro. The prize awarding ceremony is traditionally on March 14, the birthday of Paul Ehrlich, in the St. Pauls-Church, Frankfurt.

Awarded are researchers from worldwide in medicine-sections, in which Paul Ehrlich worked. Especially this are Immunology, Cancer Research, Haematology, Microbiology and experimental und clinical Chemotherapy.

The prize is given from the Paul-Ehrlich-Stiftung and belongs to the highest endowed and international most distinguished awards in medicine in Germany.

Many of the prizewinners were later Nobel Prize winners.

Prizewinners

Prizewinners 1952 - 2003

2004

For investigations of T-cell-receptors.

2005

For his experiments of cloning mammalians.

2006

For the investigations of RNA interference.

2007

For their achievements respecting structure and function of Ribosomes.

2008

For his achievements in the discovery of Th1- and Th2-cells.

2009

For their achievements in the discovery of telomeres and telomerase.

2010

For his outstanding achievements in the field of Cytokines.

2011

For his contribution to research in the field of bacterial diseases, including tetanus, botulism, anthrax and Helicobacter pylori associated diseases.

2012

For his outstanding contributions to research in the field of Cell Biology, especially for the discovery of signal recognizing particles.

2013

For her outstanding research achievements in the field of human genetics. She was the first to demonstrate that there is a genetic predisposition for breast cancer.

2014

For his outstanding achievements in the field of antibody research. He has demonstrated how the immune system's B cells are activated and induced to produce antibodies. He has thereby helped to decode the molecular bases of Paul Ehrlich's famous side-chain theory.

2015

For their outstanding contributions to research in the field of Immunotherapy against cancer.

2016

For their work that has led to the development of programmable Gene Cutter CRISPR-Cas9. These Gene Cutter is part of the bacterial immune system.


References

    External links

    This article is issued from Wikipedia - version of the Tuesday, January 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.